This is the first of two articles focused on 2023 life sciences deals in China. The second article, which is coming soon, looks at trends in M&A.
In 2023, there were 240 reported life sciences licensing deals in China, an increase of almost 50% compared to 2021.
That includes 70 out-license deals involving Chinese companies